Congenital hypothyroidism: decreased growth velocity in the first weeks of life

J Leger1, P Czernichow

  • 1Unité d'Endocrinologie Pédiatrique et Diabète, Hôpital des Enfants-Malades, Paris, France.

Biology of the Neonate
|January 1, 1989
PubMed

Insights

Infants with congenital hypothyroidism show normal birth height but decreased growth velocity, indicating immediate post-birth thyroid hormone dependence for growth. Therapy initiated catch-up growth, correlating with thyroid hormone levels.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Growth and Development

Background:

  • Congenital hypothyroidism (CH) is a condition affecting thyroid hormone production in newborns.
  • Early diagnosis and treatment are crucial to prevent developmental delays.
  • The impact of CH on early growth velocity requires further elucidation.

Purpose of the Study:

  • To analyze the growth velocity in infants with congenital hypothyroidism.
  • To assess the relationship between thyroid deficiency severity and growth patterns.
  • To determine the timing of thyroid hormone dependence for infant growth.

Main Methods:

  • Retrospective analysis of growth data from 46 infants with CH.
  • Classification of infants into athyreosis, ectopic, and eutopic gland groups.
  • Measurement of height standard deviation scores (SDS) at birth, diagnosis, and 2, 4, 8, and 12 weeks post-therapy initiation.

Main Results:

  • Infants with CH had normal birth height (0.3 SDS) but reduced growth velocity at diagnosis (-0.1 SDS).
  • Growth velocity continued to decline in the initial weeks of therapy (-0.2 SDS at 2 and 4 weeks).
  • Catch-up growth was observed after 2 weeks of therapy, reaching 0.3 SDS at 12 weeks; growth retardation correlated with thyroid deficiency severity.

Conclusions:

  • Infant growth is thyroid hormone-dependent immediately after birth.
  • Therapy for CH can restore normal growth, with catch-up growth occurring within weeks.
  • The degree of thyroid deficiency impacts growth retardation and response to therapy.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...